<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">Fatal ventricular arrhythmias in COVID-19 appear to be directly linked to the degree of cardiac enzyme release, and therefore related to myocardial damage rather than arrhythmogenicity of the disease itself.
 <xref rid="bib23" ref-type="bibr">
  <sup>23</sup>
 </xref> Therapies that produce QT prolongation have been associated with torsade de pointes.
 <xref rid="bib24" ref-type="bibr">
  <sup>24</sup>
 </xref> Around 19% of new intensive care admissions would be expected to develop new onset atrial fibrillation,
 <xref rid="bib25" ref-type="bibr">
  <sup>25</sup>
 </xref> but whilst arrhythmias do occur in 16% of patients, atrial fibrillation only makes up a proportion of this and is not a prominent feature in COVID-19.
 <xref rid="bib26" ref-type="bibr">
  <sup>26</sup>
 </xref> This is remarkable given the haemodynamic and inflammatory stress that COVID-19 presents.
</p>
